| 股票 | 富途行业 | PE | PB | 股息率 | 分红率 | 毛利率 | ROE | 固定资产 | 负债率 | OCF/市值 | 营收增速 | 利润增速 | 近60日 | YTD | 近一年 | 距52周高 | 市值亿 ▾ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Haleon HLN | 专业与通用药品制造商 | 19.6 | 1.91 | 2.0% | 39% | 64% | 10% | 5% | 50% | 8.3% | +5% | +22% | +6% | -3% | +1% | 87% | 422 |
| Liquidia LQDA | 专业与通用药品制造商 | 49.0 | 31.50 | 0.0% | 0% | 92% | -111% | 5% | 86% | 2.7% | +1031% | +46% | +5% | +99% | +145% | 73% | 61 |
| Amneal Pharmaceuticals AMRX | 专业与通用药品制造商 | 36.3 | 169.32 | 0.0% | 0% | 37% | 0% | 16% | 102% | 3.6% | +8% | +273% | +14% | +38% | +79% | 91% | 56 |
| ANI Pharmaceuticals ANIP | 专业与通用药品制造商 | 15.5 | 2.74 | 0.0% | 0% | 61% | 15% | 4% | 62% | 11.6% | +44% | +523% | -13% | -10% | -25% | 72% | 16 |
| Phibro Animal Health PAHC | 专业与通用药品制造商 | 15.7 | 4.03 | 1.2% | 20% | 34% | 30% | 25% | 74% | 4.4% | +17% | +107% | +23% | +3% | -2% | 64% | 16 |
| Pacira BioSciences PCRX | 专业与通用药品制造商 | 75.3 | 1.56 | 0.0% | 0% | 79% | 1% | 12% | 45% | 17.9% | +4% | +107% | +12% | +2% | -2% | 95% | 11 |
| Kamada KMDA | 专业与通用药品制造商 | 22.5 | 1.83 | 2.9% | 66% | 42% | 8% | 15% | 29% | 7.3% | +12% | +40% | +21% | +27% | +24% | 96% | 5 |
点表头排序。市值单位亿美元;财务为最近年报(futu 筛选器);分红率 = 股息率 × PE;OCF/市值 = 经营现金流 ÷ 市值(无 FCF);距52周高 = 现价 / 52 周最高。